More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

Changes to the ways in which the FDA plans to regulate vaccines represent a threat to effective vaccines and public health, ...

The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...

An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

White House Coronavirus Task Force member Dr. Anthony Fauci said that Pfizer’s Covid-19 vaccine breakthrough could result in other vaccine candidates also being successful. After it was reported this ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose. This price model comes down to ...

The study will examine vaccine safety, efficacy and immunity at lower doses. Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical ...